Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1996-4-9
|
pubmed:abstractText |
Streptozotocin-diabetes as a model for insulin-deficient Type 1 diabetes leads to cardiomyopathy, characterized by a 50% reduced glucose uptake (P < 0.001) and increased lactate and pyruvate levels (P < 0.001), i.e. a reduced glucose utilization by the heart. As thioctic acid (TA) has favourable effects on glucose metabolism, the influence of this drug at two different doses (0.1 mg/ml and 0.5 mg/ml, added to the perfusion medium) was investigated in the heart after 2 weeks of diabetes, using the working rat heart model at physiological workload about 45 min. TA at high doses led to a normalization of glucose uptake (P < 0.001) and glucose utilization, and consequently to a normalization of oxygen uptake (P < 0.001), myocardial ATP levels (P < 0.001) as well as cardiac output (P < 0.05). Whereas a low dose of TA resulted in a normalization of lactate and pyruvate production (P < 0.001), neither a normalization of glucose utilization nor of cardiac output was achieved by this low dosage. Additionally, TA improved at both doses utilization of endogenous glycogen in the diabetic heart (P < 0.001), the latter here already delivering 45% of the utilized glucose. TA acts especially by increasing glucose uptake, glycogen breakdown and glucose oxidation. Thus, metabolic and hemodynamic sequelae of insulin-deficiency in the heart can be corrected by TA. Due to its anti-diabetic effects on cardiac metabolism, TA could be considered an adjuvant therapy in diabetic cardiomyopathy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0168-8227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-26
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8593755-Adenosine Triphosphate,
pubmed-meshheading:8593755-Animals,
pubmed-meshheading:8593755-Cardiac Output,
pubmed-meshheading:8593755-Cardiomyopathies,
pubmed-meshheading:8593755-Diabetes Mellitus, Experimental,
pubmed-meshheading:8593755-Diabetes Mellitus, Type 1,
pubmed-meshheading:8593755-Glucose,
pubmed-meshheading:8593755-Heart,
pubmed-meshheading:8593755-Male,
pubmed-meshheading:8593755-Myocardium,
pubmed-meshheading:8593755-Rats,
pubmed-meshheading:8593755-Rats, Wistar,
pubmed-meshheading:8593755-Thioctic Acid
|
pubmed:year |
1995
|
pubmed:articleTitle |
The influence of thioctic acid on metabolism and function of the diabetic heart.
|
pubmed:affiliation |
Medical Clinic III, University of Giessen, Germany.
|
pubmed:publicationType |
Journal Article
|